The Sbi protein contributes to Staphylococcus aureus inflammatory response during systemic infection

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Gonzalez, Cintia Daniela ^a   Ledo, Camila ^a   Giai, Constanza ^a   Garófalo, Ailin ^a   Gómez, Marisa I ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; CXCL1 CHEMOKINE; CYTOKINE; EPIDERMAL GROWTH FACTOR RECEPTOR; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN SBI; PROTEIN TNFR1; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; UNCLASSIFIED DRUG; VIRULENCE FACTOR; 2-(2-AMINO-3-METHOXYPHENYL)-4H-1-BENZOPYRAN-4-ONE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; 4-(4-FLUOROPHENYL)-2-(4-HYDROXYPHENYL)-5-(4-PYRIDYL)IMIDAZOLE; CARRIER PROTEIN; CXCL1 PROTEIN, MOUSE; EGFR PROTEIN, MOUSE; FLAVONOID; IMIDAZOLE DERIVATIVE; IMMUNOGLOBULIN G; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE INHIBITOR; PYRIDINE DERIVATIVE; QUINAZOLINE DERIVATIVE; SBI PROTEIN, STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS PROTEIN A; TUMOR NECROSIS FACTOR RECEPTOR 1; TYRPHOSTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; CYTOKINE PRODUCTION; DOWNSTREAM PROCESSING; FEMALE; IN VIVO STUDY; MOLECULAR CLONING; MOUSE; NEUTROPHIL; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; ANIMAL; ANTAGONISTS AND INHIBITORS; ANTIBODY COMBINING SITE; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; GENETICS; IMMUNOLOGY; INFLAMMATION; METABOLISM; MICROBIOLOGY; NEUTROPHIL CHEMOTAXIS; TRANSGENIC MOUSE;

STAPHYLOCOCCUS AUREUS;

ANIMALS; BACTERIAL PROTEINS; BINDING SITES, ANTIBODY; CARRIER PROTEINS; CHEMOKINE CXCL1; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; FLAVONOIDS; IMIDAZOLES; IMMUNOGLOBULIN G; INFLAMMATION; INTERLEUKIN-6; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; NEUTROPHIL INFILTRATION; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE INHIBITORS; PYRIDINES; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SIGNAL TRANSDUCTION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL PROTEIN A; STAPHYLOCOCCUS AUREUS; TYRPHOSTINS; VIRULENCE FACTORS;

EID: 84938710049     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0131879     Document Type: Article

References (44)

1. Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998;(339): 520-532.
2. Lowy FD. Secrets of a superbug. Nat Med. 2007;(13): 1418-20. PMID: 18064034
3. Fournier B, Philpott DJ. Recognition of Staphylococcus aureus by the Innate Immune System. Clin Microbiol Rev. 2005;(18): 521-540. doi: 10.1128/CMR.18.3.521-540.2005 PMID: 16020688
4. Gómez MI, Lee A, Reddy B, Muir A, Soong G, Pitt A, et al. Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1. Nat Med. 2004;(10): 842-8. doi: 10.1038/nm1079 PMID: 15247912
5. Gómez MI, Seaghdha MO, Prince AS. Staphylococcus aureus protein A activates TACE through EGFR-dependent signaling. EMBO J. 2007;(26): 701-9. doi: 10.1038/sj.emboj.7601554 PMID: 17255933
6. Gómez MI, O'Seaghdha M, Magargee M, Foster TJ, Prince AS. Staphylococcus aureus protein A activates TNFR1 signaling through conserved IgG binding domains. J Biol Chem. 2006;(281): 20190-6. doi: 10.1074/jbc.M601956200 PMID: 16709567
7. Foster TJ. Immune evasion by staphylococci. Nat Rev Microbiol. 2005;(3): 948-58.
8. Postma B, Kleibeuker W, Miriam JJ, Poppelier G, Boonstra M, Kok PM, et al. Residues 10- 18 within the C5a Receptor N Terminus Compose a Binding Domain for Chemotaxis Inhibitory Protein of Staphylococcus aureus. J Biol Chem. 2005;(280): 2020-2027. doi: 10.1074/jbc.M412230200 PMID: 15542591
9. Hair PS, Ward MD, Semmes OJ, Foster TJ, Cunnion KM. Staphylococcus aureus clumping factor A binds to complement regulator factor I and increases factor I cleavage of C3b. J Infect Dis. 2008;(198): 125-33. doi: 10.1086/588825 PMID: 18544012
10. Rooijakkers SHM, Wu J, Ruyken M, Domselaar R Van, Karel L. Structural and functional implications of the complement convertase stabilized by a staphylococcal inhibitor. Nat Inmunol. 2009;(10): 721-727.
11. Chen H, Ricklin D, Hammel M, Garcia BL, McWhorter WJ, Sfyroera G, et al. Allosteric inhibition of complement function by a staphylococcal immune evasion protein. Proc Natl Acad Sci U S A. 2010;(107): 17621-6. doi: 10.1073/pnas.1003750107 PMID: 20876141
12. Foster TJ, Geoghegan J, Ganesh V, Höök M. Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus. Nat Rev Microbiol. 2014;(12): 49-62. doi: 10.1038/nrmicro3161.Adhesion PMID: 24336184
13. Zhang L, Jacobson K, Vasi J, Lindberg M, Frykberg L. A second IgG-binding protein in Staphylococcus aureus. Microbiology. 1998;(144): 985-991. PMID: 9579072
14. Zhang L, Jacobsson K, Ström K, Lindberg M, Frykberg L. Staphylococcus aureus expresses a cell surface protein that bind both IgG and β2-glycoprotein I. Microbiology. 1999;(145): 177-183. PMID: 10206697
15. Atkins KL, Burman JD, Chamberlain ES, Cooper JE, Poutrel B, Bagby S, et al. S. aureus IgG-binding proteins SpA and Sbi: Host specificity and mechanisms of immune complex formation. Mol Immunol. 2008;(45): 1600-1611. doi: 10.1016/j.molimm.2007.10.021 PMID: 18061675
16. Burman JD, Leung E, Atkins KL, Seaghdha MNO, Bernadó P, Bagby S, et al. Interaction of Human Complement with Sbi, a Staphylococcal Immunoglobulin-binding Protein: indications of a novel mechanism of complement evasion by Staphylococcus aureus. J Biol Chem. 2008;(283): 17579-17593. PMID: 18434316
17. Smith EJ, Corrigan RM, van der Sluis T, Gründling A, Speziale P, Geoghegan J a, et al. The immune evasion protein Sbi of Staphylococcus aureus occurs both extracellularly and anchored to the cell envelope by binding lipoteichoic acid. Mol Microbiol. 2011;(83): 789-804. doi: 10.1111/j.1365-2958.2011.07966.x
18. Smith EJ, Visai L, Kerrigan SW, Speziale P, Foster TJ. The Sbi protein is a multifunctional immune evasion factor of Staphylococcus aureus. Infect Immun. 2011;(79): 3801-9. doi: 10.1128/IAI.05075-11 PMID: 21708997
19. National Institutes of Health. Guide for the care and use of laboratory animals. Washington, DC: National Research Council Guide, 1996.
20. Zhang L, Rosander a, Jacobsson K, Lindberg M, Frykberg L. Expression of staphylococcal protein Sbi is induced by human IgG. FEMS Immunol Med Microbiol. 2000;(28): 211-8. Available: http://www.ncbi.nlm.nih.gov/pubmed/10865173 PMID: 10865173
21. Malachowa N, Whitney AR, Kobayashi SD, Sturdevant DE, Kennedy AD, Braughton KR, et al. Global changes in Staphylococcus aureus gene expression in human blood. PLoS One. 2011;(6): e18617. doi: 10.1371/journal.pone.0018617 PMID: 21525981
22. Giai C, Gonzalez C, Ledo C, Garofalo A, Di Genaro MS, Sordelli DO, et al. Shedding of tumor necrosis factor receptor 1 induced by protein A decreases tumor necrosis factor alpha availability and inflammation during systemic Staphylococcus aureus infection. Infect Immun. 2013;(81): 4200-7. doi: 10.1128/IAI.00593-13 PMID: 24002060
23. Becker S, Frankel MB, Schneewind O, Missiakas D. Release of protein A from the cell wall of Staphylococcus aureus. Proc Natl Acad Sci U S A. 2014;(111): 1574-9. doi: 10.1073/pnas.1317181111 PMID: 24434550
24. DeDent A, Bae T, Missiakas DM, Schneewind O. Signal peptides direct surface proteins to two distinct envelope locations of Staphylococcus aureus. EMBO J. 2008;(27): 2656-68. doi: 10.1038/emboj.2008.185 PMID: 18800056
25. Remick DG, Siddiqui J, Shin J, Bolgos GR, Nemzek JA. Six at six: interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 days. Shock. 2002;(17): 463-467. PMID: 12069181
26. Turnbull IR, Javadi P, Buchman TG, Hotchkiss RS, Karl IE, Coopersmith C. Antibiotics improve survival in sepsis independent of injury severity but do not change mortality in mice with markedly elevated interleukin 6 levels. Shock. 2004;(21): 121-125. PMID: 14752284
27. Gennari R, Alexander JW. Anti-interleukin-6 antibody treatment improves survival during gut-derived sepsis in a time-dependent manner by enhancing host defense. Crit Care Med. 1995;(23): 1945-53. Available: http://www.ncbi.nlm.nih.gov/pubmed/7497716 PMID: 7497716
28. Riedemann NC, Neff T a, Guo R-F, Bernacki KD, Laudes IJ, Sarma JV, et al. Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression. J Immunol. 2003;(170): 503-7. Available: http://www.ncbi.nlm.nih.gov/pubmed/12496437 PMID: 12496437
29. Dalrymple S a, Lucian L a, Slattery R, McNeil T, Aud DM, Fuchino S, et al. Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia. Infect Immun. 1995;(63): 2262-8. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=173295&tool=pmcentrez&rendertype=abstract PMID: 7768607
30. Dalrymple S a, Slattery R, Aud DM, Krishna M, Lucian L a, Murray R. Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection. Infect Immun. 1996;(64): 3231-5. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=174212&tool=pmcentrez&rendertype=abstract PMID: 8757858
31. Ladel CH, Blum C, Dreher a, Reifenberg K, Kopf M, Kaufmann SH. Lethal tuberculosis in interleukin-6-deficient mutant mice. Infect Immun. 1997;(65): 4843-9. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=175695&tool=pmcentrez&rendertype=abstract PMID: 9353074
32. Hume EBH, Cole N, Garthwaite LL, Khan S, Willcox MDP. A protective role for IL-6 in staphylococcal microbial keratitis. Invest Ophthalmol Vis Sci. 2006;(47): 4926-30. doi: 10.1167/iovs.06-0340 PMID: 17065508
33. Barillé S, Bataille R, Amiot M. The role of interleukin-6 and interleukin-6/interleukin-6 receptor-a complex in the pathogenesis of multiple myeloma. Eur Cytokine Netw. 2000;(11): 546-51. PMID: 11125296
34. Atreya R, Mudter J, Finotto S, Müllberg J, Jostock T, Wirtz S, et al. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo. Nat Med. 2000;(6): 583-8. doi: 10.1038/75068 PMID: 10802717
35. Peake NJ, Khawaja K, Myers a, Nowell M a, Jones S a, Rowan a D, et al. Interleukin-6 signalling in juvenile idiopathic arthritis is limited by proteolytically cleaved soluble interleukin-6 receptor. Rheumatology (Oxford). 2006;(45): 1485-9. doi: 10.1093/rheumatology/kel154
36. Rabe B, Chalaris A, May U, Waetzig GH, Seegert D, Williams AS, et al. Transgenic blockade of interleukin 6 transsignaling abrogates inflammation. Blood. 2008;(111): 1021-8. doi: 10.1182/blood-2007-07-102137 PMID: 17989316
37. Scheller J, Chalaris A, Schmidt-arras D, Rose-john S. Biochimica et Biophysica Acta The pro- and anti-in flammatory properties of the cytokine interleukin-6. 2011;(1813): 878-888. doi: 10.1016/j.bbamcr.2011.01.034
38. Chalaris A, Garbers C, Rabe B, Rose-John S, Scheller J. The soluble Interleukin 6 receptor: generation and role in inflammation and cancer. Eur J Cell Biol. Elsevier GmbH.; 2011;(90): 484-94. doi: 10.1016/j.ejcb.2010.10.007
39. Gómez MI, Sokol SH, Muir AB, Soong G, Bastien J, Prince AS. Bacterial Induction of TNF-α Converting Converting Enzyme Expression and IL-6 Receptor α Shedding Regulates Airway Inflammatory Signaling. J Immunol. 2005;(175): 1930-1936. doi: 10.4049/jimmunol.175.3.1930 PMID: 16034137
40. Yimin KM, Zhao S, Ozaki M, Haga S, Nan G, Kuge Y, et al. Contribution of toll-like receptor 2 to the innate response against Staphylococcus aureus infection in mice. PLoS One. 2013;(8): e74287. doi: 10.1371/journal.pone.0074287 PMID: 24058538
41. Chabelskaya S, Gaillot O, Felden B. A Staphylococcus aureus small RNA is required for bacterial virulence and regulates the expression of an immune-evasion molecule. PLoS Pathog. 2010;(6): e1000927. doi: 10.1371/journal.ppat.1000927 PMID: 20532214
42. Nygaard TK, Pallister KB, Ruzevich P, Griffith S, Vuong C, Voyich JM. SaeR Binds a Consensus Sequence within Virulence Gene Promoters to Advance USA300 Pathogenesis. J Infect Dis. 2010;(201): 241-254. doi: 10.1086/649570 PMID: 20001858
43. Watkins RL, Pallister KB, Voyich JM. The SaeR/S gene regulatory system induces a pro-inflammatory cytokine response during Staphylococcus aureus infection. PLoS One. 2011;(6): e19939. doi: 10.1371/journal.pone.0019939 PMID: 21603642
44. Benson M a, Lilo S, Wasserman G a, Thoendel M, Smith A, Horswill AR, et al. Staphylococcus aureus regulates the expression and production of the staphylococcal superantigen-like secreted proteins in a Rot-dependent manner. Mol Microbiol. 2011;(81): 659-75. doi: 10.1111/j.1365-2958.2011.07720.x PMID: 21651625